
What We’re Reading: Tenapanor Recommended for Dialysis; Home Births Up During Pandemic; Call for RSV, Flu Emergency
FDA advisers voted in favor of approving Ardelyx’s tenapanor for patients with chronic kidney disease on dialysis; US home births increased by about 12% between 2020 and 2021; surges in respiratory viruses, especially respiratory syncytial virus (RSV) among younger children are putting pediatric hospitals at capacity.
FDA Advisers in Favor of Tenapanor for Patients With CKD on Dialysis
More than a year after initially rejecting the drug, a panel of FDA advisers recommended the approval of Ardelyx’s tenapanor for patients with chronic kidney disease (CKD) on dialysis,
Home Births Increased in US During COVID-19 Pandemic
A recent CDC
Surge in Hospitalizations for Pediatric Respiratory Illnesses
Pediatric health provider groups are calling for the Biden administration to declare a national emergency for pediatric respiratory illnesses to help combat a surge in hospitalizations,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.















































